• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 251/18 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines

Patent holdings for IPC class C07D 251/18

Total number of patents in this class: 190

10-year publication summary

23
7
12
8
7
9
5
11
11
6
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
BASF SE
21135
18
Servier Pharmaceuticals, LLC
111
17
Agios Pharmaceuticals, Inc
220
7
Emory University
1692
7
Anji Pharmaceuticals Inc.
31
7
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
739
6
Centaurus Biopharma Co., Ltd.
82
5
Lianyungang Runzhong Pharmaceutical Co., Ltd.
84
5
Pfizer Inc.
3394
4
ADAMA Agan Ltd.
410
4
Luoda Biosciences, Inc.
6
4
Aluda Pharmaceuticals, Inc.
5
4
AstraZeneca AB
2837
3
Bayer Cropscience AG
1929
3
Takeda Pharmaceutical Company Limited
2728
3
Betta Pharmaceuticals Co., Ltd.
177
3
The United States Government AS represented by The Department of Veterans Affairs
1282
3
University of Basel
46
3
LG Chem, Ltd.
17786
2
Centre National de La Recherche Scientifique
10855
2
Other owners 80